## Abstract We have analyzed the effect of Cyclosporin‐A (CsA) on the in vitro suppression of Epstein‐Barr virus (EBV)‐induced B‐cell proliferation exerted by autologous T‐lymphocyte subpopulations separated on the basis of cell density. CsA abolished the growth‐inhibitory capacity of high‐density
Effects of cyclosporin A on the immune system of the mouse. I. Evidence for a direct selective effect of cyclosporin A on B cells responding to anti-immunoglobulin antibodies
✍ Scribed by David W. Dongworth; Gerhard G. B. Klaus
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 535 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Previous in vivo studies have shown that the immunsuppressive peptide cyclosporin A (CsA) selectively suppresses antibody responses to nonmitogenic T‐independent (TI‐2) antigens, but not those to mitogenic (TI‐1) antigens. This report demonstrates that in vitro CsA suppresses the polyclonal proliferative response of B cells to anti‐Ig (anti‐μ) antibodies at 300‐400‐fold lower doses than are required to inhibit B cell proliferation induced by lipopolysaccharide. Since the proliferative response to anti‐μ requires neither T cells nor macrophages, it is concluded that CsA has a direct inhibitory effect on the B cells responding to this mitogen. The data support the concept that the B cells responding to TI‐2 antigens are contained within the population which is stimulated polyclonally by anti‐μ, and that lipopolysaccharide stimulates a distinct B cell subpopulation. They do not, however, exclude the possibility that anti‐μ. and lipopolysaccharide stimulate the same B cell population via two biochemically distinct triggering mechanisms, one of which is CsA‐sensitive and the other CsA‐resistant.
📜 SIMILAR VOLUMES